Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-10-22FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for AMNESTEEM (isotretinoin) from Mylan Pharmaceuticals Inc. Isotretinoin is used to treat severe ac…
-
FDA approval · 2010-10-18FDA Approved: ACANYA — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for ACANYA (clindamycin phosphate and benzoyl peroxide) from Bausch Health US, LLC.
-
FDA approval · 2010-09-29FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic topical product combining clindamycin phosphate and benzoyl peroxide for acne, manufac…
-
CLINICAL_TRIALS trial_result · 2010-09-24Clinical Trial Update: Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance [Phase 3]
Phase 3 trial update on adapalene-benzoyl peroxide gel for 6-month maintenance therapy in acne vulgaris; results posted after completion.
-
FDA approval · 2010-09-14FDA Approved: MINOCIN — Supplemental Application (Melinta Therapeutics, LLC)
FDA approved a supplemental application for MINOCIN (minocycline hydrochloride) filed by Melinta Therapeutics, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-09-01FDA Approved: ADAPALENE — Supplemental Application (Mayne Pharma Commercial LLC.)
FDA approved a supplemental application for adapalene submitted by Mayne Pharma Commercial LLC., resulting in an approved update to the prod…
-
CLINICAL_TRIALS trial_result · 2010-08-31Clinical Trial Update: Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate Acne [Phase 4]
A Phase 4 trial compares benzoyl peroxide plus clindamycin versus benzoyl peroxide plus clindamycin and doxycycline for moderate acne, asses…
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Acne Treatment With Active Patches Which Contains Azelaic Acid, Citric Acid,Salicylic Acid and 2% Ascorbic Acid [Phase 1, Phase 2]
Phase 1 and Phase 2 trials evaluating an acne patch containing azelaic acid, citric acid, salicylic acid, and 2% ascorbic acid have complete…
-
CLINICAL_TRIALS trial_result · 2010-07-23Clinical Trial Update: Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne [Phase 4]
A Phase 4 trial compared the antimicrobial efficacy of two topical acne therapies for facial acne and has completed results.
-
CLINICAL_TRIALS trial_result · 2010-07-12Clinical Trial Update: A Study to Determine the Safety and Efficacy of an Ultrasound Device in the Management of Acute Acne Lesions [Phase 1]
Phase 1 clinical trial update assessing the safety and preliminary efficacy of an ultrasound device for managing acute acne lesions (Acne vu…
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: Comparison of Two Salicylic Acid Formulations [NA]
A completed clinical trial comparing two topical salicylic acid formulations for acne vulgaris, with results posted in 2010.
-
FDA approval · 2010-07-01FDA Approved: ADAPALENE — Original Application (TOP CARE (Topco Associates LLC))
The FDA approved TOP CARE's adapalene 0.1% topical formulation under an original application for the treatment of acne vulgaris.
-
FDA approval · 2010-06-30FDA Approved: ADAPALENE — Original Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
FDA approved the original application for a generic adapalene product (ANDA090824) from E. Fougera & Co., a division of Fougera Pharmaceutic…
-
FDA approval · 2010-06-23FDA Approved: ACANYA — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for ACANYA (clindamycin phosphate and benzoyl peroxide) from Bausch Health US, LLC.
-
FDA approval · 2010-06-17FDA Approved: CLINDAMYCIN PHOSPHATE — Original Application (i3 Pharmaceuticals, LLC)
FDA approved the original application for CLINDAMYCIN PHOSPHATE TOPICAL (clindamycin phosphate topical) by i3 Pharmaceuticals, LLC as a gene…
-
FDA approval · 2010-06-02FDA Approved: ADAPALENE — Original Application (Walgreens)
FDA approved Walgreens' original application for a generic adapalene product to treat acne vulgaris.
-
CLINICAL_TRIALS trial_result · 2010-05-25Clinical Trial Update: Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate [Phase 3]
A Phase 3 safety and efficacy trial evaluated the combination of tretinoin and clindamycin for mild-to-moderate acne vulgaris; the study has…
-
CLINICAL_TRIALS trial_result · 2010-05-20Clinical Trial Update: Efficacy & Safety of Clindamycin and Tretinoin in Acne [Phase 4]
Phase 4 trial evaluating the efficacy and safety of a clindamycin phosphate and tretinoin topical combination for acne.
-
CLINICAL_TRIALS trial_result · 2010-04-09Clinical Trial Update: Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face [Phase 4]
A Phase 4 clinical trial evaluated whether two facial gels applied to opposite sides of the face could cause irritation in people with acne …
-
CLINICAL_TRIALS trial_result · 2010-03-31Clinical Trial Update: Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris [Phase 3]
Phase 3 trial update for adapalene-BPO gel with doxycycline in severe acne vulgaris completed with results posted.
-
CLINICAL_TRIALS trial_result · 2010-03-30Clinical Trial Update: Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel [NA]
A completed clinical trial comparing 0.3% adapalene gel to Differin 0.3% adapalene gel for acne vulgaris.
-
FDA approval · 2010-03-25FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for Claravis (isotretinoin). This action represents an approved modification to the product…
-
FDA approval · 2010-03-25FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for AMNESTEEM (isotretinoin) from Mylan Pharmaceuticals Inc.
-
FDA approval · 2010-03-25FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for CLARAVIS (isotretinoin) filed by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS research · 2010-03-19Clinical Trial Update: Open and Comparative Study to Measure Tolerability and Efficacy of Taro Elixir [Phase 3]
This is a Phase 3 open and comparative trial evaluating tolerability and efficacy of Taro Elixir for acne vulgaris and furuncles, sponsored …